TargED Biopharmaceuticals
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
$44M Series A ·
Led by Andera Partners · Source: startupintros.com
Latest round on record: Series A, July 2025, amount undisclosed.
All 2 rounds ↓Signals
TargED Biopharmaceuticals | 574 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Series A · $44M
AAndera Partners (lead),
FFund+ (lead),
HHadean Ventures (lead),
IInkef (lead),
SSunstone Life Science Ventures (lead),
CCurie Capital, FFirst,
UUtrecht Health Seed Fund
Source: startupintros.com - Website created
Team
KV
Kristof Vercruysse CEORF
Roger Franklin Director
Investors
AAndera Partnerslead investor
BBioGeneration Ventures
CCurie Capital
EEIC Accelerator
EEuropean Innovation Council Fund
- FFirst
FFund+lead investor
HHadean Ventureslead investor
IInkeflead investor
SSunstone Life Science Ventureslead investor
UUtrecht Health Seed Fund
Companies like TargED Biopharmaceuticals
RR1 Therapeutics$80.5M Series A · Sep 2026
LLuofang BiotechnologySeed · Apr 2026
OOncusp TherapeuticsSeries A · Nov 2025PParatus Sciences$100M Series A · Mar 2023
MModel Medicines$4.1M · Nov 2021
OOncoC4$50M Series B+ · Oct 2025
Other companies backed by Andera Partners
NNouscom$135.04M Series B+ · Oct 2026
MMMI$125M Series B+ · Oct 2026
TTubulis$360M Series B+ · Oct 2025SSciRhom$68M Series A · Jul 2024
GGrey Wolf Therapeutics$50M Series B+ · May 2024
AAmolyt Pharma$140M Series B+ · Jan 2023
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/targed-biopharmaceuticals (get a free API key).